1-4 of 4
Frank van Leeuwen
Close
Sort by
Journal Articles

Methionine Restriction As a Novel Therapeutic Strategy for MLL ( KMT2A) -Rearranged Acute Lymphoblastic Leukemia

Trisha Tee, Titine Ruiter, Ahmed Dahaoui, Dorette van Ingen Schenau, Rico Hagelaar, Laurens van der Meer, Frank van Leeuwen
Journal: Blood
Blood (2021) 138 (Supplement 1): 2269.
https://doi.org/10.1182/blood-2021-145308
Published: 2021
Journal Articles

Glucocorticoid Resistance in IKZF1-Deleted BCP-ALL: It Is PTEN Again

Laurens Van Der Meer, PhD, Rene Marke, MSc, Miriam Butler, MSc, Dorette van Ingen Schenau, MSc, Blanca Scheijen, PhD, Frank van Leeuwen, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4088.
https://doi.org/10.1182/blood-2018-99-112888
Published: 2018
Journal Articles

A CRISPR/Cas9 Based Kinome Screen Identifies Bruton Tyrosine Kinase (BTK) As an Important Determinant of Asparaginase Treatment Response in Acute Lymphoblastic Leukemia

Miriam Butler, MSc, Laurens Van Der Meer, PhD, Jiangyan Yu, Silvia Jenni, PhD, Maria Pamela Dobay, PhD, Peter Hoogerbrugge, MD, Beat Bornhauser, PhD, Jean-Pierre Bourquin, MD PhD, Roland P. Kuiper, PhD, Frank van Leeuwen, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 34.
https://doi.org/10.1182/blood.V130.Suppl_1.34.34
Published: 2017
Journal Articles

Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL

Arian van der Veer, Esmé Waanders, Rob Pieters, Marieke E. Willemse, Simon V. Van Reijmersdal, Lisa J. Russell, Christine J. Harrison, William E. Evans, Vincent H. J. van der Velden, Peter M. Hoogerbrugge, Frank Van Leeuwen, Gabriele Escherich, Martin A. Horstmann, Leila Mohammadi Khankahdani, Dimitris Rizopoulos, Hester A. De Groot-Kruseman, Edwin Sonneveld, Roland P. Kuiper, Monique L. Den Boer
Journal: Blood
Blood (2013) 122 (15): 2622–2629.
https://doi.org/10.1182/blood-2012-10-462358
Published: 2013
Includes: Supplemental data